Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001213900-20-015639

Director bought 289,118 shares at $5.00 ($1,445,590)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sunderland Julie Director 2020-06-19 Purchase +289,118 $5.00 $1,445,590 2,502,025 I
Open-market purchases · 289,118 sh · avg $5.00 · $1,445,590
Loading xslF345X03/ownership.xml…